CAMBRIDGE, Mass. — TileDB has announced the launch of TileDB Carrara, the omnimodal data intelligence platform, as a Snowflake Connected App for Healthcare & Life Sciences. This integration enables organizations to unify complex scientific and multimodal data—including genomics, proteomics, medical imaging, and documents—that live in both TileDB and Snowflake, providing a unified view and streamlined […]
Partnership expands BC Platforms’ global patient catchment to include an additional 48 million patient lives across Asia, the Middle East, Africa, and Latin America ZURICH — BC Platforms, a global leader in healthcare data technology and analytics, today announced a major expansion of its global data capabilities through a strategic partnership with GeneVault Lifesciences™️, a data intelligence […]
Revolutionary model represents a transformative step toward AI-powered virtual tissues, patient digital twins, and a new era of data-driven biomedical innovation The Unveiling of M-Optimus: Bioptimus has trained its inaugural World Model for biology – a foundation model that learns interactions across multiple languages of biology – marking a revolutionary first step in simulating the full […]
New AI Models-as-a-Service offering to integrate in-silico design with experimental data to continuously improve predictive power and accelerate scientific innovation WALTHAM, Mass. — Revvity, Inc. (NYSE: RVTY) today announced the introduction of its forthcoming Signals Xynthetica™ Models-as-a Service (MaaS) AI offering within the Revvity Signals platform. The Signals Xynthetica offering will enable AI-augmented molecular and materials design, and brings together […]
Lausanne, Switzerland – Saphetor SA, a Swiss precision medicine company and creator of the VarSome suite of bioinformatics solutions, today announced the appointment of Esteban Czwan as Chief Commercial Officer, effective 5th December 2025. Esteban will be responsible for global commercial strategy and activity as Saphetor continues its expansion into key markets. “We are all […]
Toronto — BenchSci, a leading provider of AI software for biopharma research and development, today announced a renewed two-year contract with Merck, known as MSD outside of the United States and Canada. “Seeing Merck’s teams use ASCEND to unravel disease biology, strengthen hypotheses, and make more evidence-driven decisions underscores the real scientific value AI can […]
Team to develop and validate computational models trained on data from organoids and advanced human model systems that will improve drug safety and reduce reliance on animal testing NEW YORK — Inductive Bio, an AI drug discovery partner developing virtual chemistry labs, announced today that it has received an up to $21M award to lead a […]
We’re proud to highlight that Tyrolpath, the largest private pathology lab in western Austria, is the first lab in Austria to adopt MSK-IMPACT®-Flex powered with SOPHiA DDM™, marking a major milestone for precision oncology in the country. With approximately 45,000 new cancer diagnoses reported each year, there is a strong need for comprehensive genomic profiling (CGP) to identify […]
DNASTAR is pleased to announce a new distribution partnership with ONEOMICS PRIVATE LIMITED, now serving as the authorized representative for Lasergene® bioinformatics software in South India. Through this collaboration, researchers across the region will gain expanded access to the full range of DNASTAR tools for genomics, molecular biology, and structural biology, supported by dedicated local […]
Proprietary agentic AI model transforms genomic and real-world data into actionable insights across the full drug lifecycle Enables faster development of breakthrough therapies, including tumor-agnostic cancer treatments, through a 360-degree view of the precision medicine landscape Empowers scientific researchers across the life sciences and healthcare continuum to perform large-scale data analysis for the advancement of […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
